A novel monoclonal antibody against the Nipah virus is set to undergo human clinical trials in India, and Bangladesh -- two countries that suffer Nipah outbreaks almost every year -- in 2025, according to a report on Thursday.
Before World Cancer Day (4 February), a new study from the University of Southampton's Centre for Cancer Immunology demonstrated that altering how tightly an antibody attaches to a target could enhance cancer therapies.
The team found that 98.8 per cent of people infected in February/March showed detectable levels of antibodies in November, and there was no difference between people who had suffered symptoms of Covid-19 and those that had been symptom-free.
Patients should be monitored during the infusion and observed for least one hour after the completion of the infusion and 15--30 minutes after the subcutaneous injection.
These teams will collect blood samples of 2,500 citizens of Berhampur for analysis. Out of them 1,000 residents will be from high risk categories, while the other 1,500 blood samples will be collected randomly.
Japanese researchers have developed an antibody that induces immune responses, which significantly suppresses malignant cancers in dogs as well as…
Researchers have found that an antibody — originally developed for studying the autoimmune condition multiple sclerosis — can promote the…
Scientists have identified an antibody that potently neutralises nearly all HIV strains and may potentially help treat or prevent the…
